Lilly to expand partnership with Korean drug makers

Published: 2007-08-28 07:00:00

Updated: 2007-08-28 07:00:00

Eli Lilly and Company a leading innovation-driven corporation, plans to create its ambitious partnership with Korean pharmaceutical companies for joint research and development (R&D) of new drugs and medical technology in the years to come, according to the pharmaceutical sources.

Some of Eli ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK